RENVELA
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $25,664 | 8 | 1 |
| 2018 | $266.62 | 14 | 14 |
| 2017 | $132,149 | 2,266 | 1,246 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $79,829 | 10 | 50.5% |
| Food and Beverage | $40,183 | 2,244 | 25.4% |
| Travel and Lodging | $27,238 | 24 | 17.2% |
| Unspecified | $5,498 | 7 | 3.5% |
| Consulting Fee | $5,332 | 3 | 3.4% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease | GENZYME CORPORATION | $5,498 | 7 |
Top Doctors Receiving Payments for RENVELA — Page 49
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Nephrology | Columbia, SC | $11.72 | 1 |
| , M.D | Nephrology | Park Ridge, IL | $11.71 | 1 |
| , MD | Nephrology | Fort Dodge, IA | $11.65 | 1 |
| , M.D | Nephrology | Phoenix, AZ | $11.56 | 1 |
| , M.D | Nephrology | Paterson, NJ | $11.50 | 1 |
| , MD | Nephrology | Oklahoma City, OK | $11.49 | 1 |
| , M.D | Specialist | Bayamon, PR | $11.46 | 1 |
| , M.D | Specialist | Savannah, GA | $11.45 | 1 |
| , M.D | Nephrology | Chicago, IL | $11.45 | 1 |
| , M.D | Nephrology | Merrillville, IN | $11.44 | 1 |
| , M.D | Nephrology | Thomasville, GA | $11.44 | 1 |
| , MD | Nephrology | Merrillville, IN | $11.44 | 1 |
| , M.D | Nephrology | Alexandria, LA | $11.42 | 1 |
| , D.O | Nephrology | Flagstaff, AZ | $11.37 | 1 |
| , M.D | Nephrology | Phoenix, AZ | $11.37 | 1 |
| , M.D | Internal Medicine | Birmingham, AL | $11.37 | 1 |
| , D.O | Nephrology | Indianapolis, IN | $11.36 | 1 |
| , MD | Nephrology | Indianapolis, IN | $11.36 | 1 |
| , MD | Internal Medicine | Wichita, KS | $11.34 | 1 |
| , M.D | Nephrology | Wichita, KS | $11.34 | 1 |
| , MD | Internal Medicine | Wayne, NJ | $11.33 | 1 |
| , MD | Nephrology | Jacksonville, FL | $11.28 | 1 |
| , MD | Nephrology | Sioux Falls, SD | $11.26 | 1 |
| , M.D | Internal Medicine | Nashville, TN | $11.25 | 1 |
| , M.D | Nephrology | San Antonio, TX | $11.24 | 1 |
Manufacturing Companies
- SANOFI-AVENTIS U.S. LLC $131,370
- GENZYME CORPORATION $26,710
Product Information
- Type Drug
- Total Payments $158,080
- Total Doctors 1,251
- Transactions 2,288
About RENVELA
RENVELA is a drug associated with $158,080 in payments to 1,251 healthcare providers, recorded across 2,288 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI-AVENTIS U.S. LLC.
Payment data is available from 2017 to 2019. In 2019, $25,664 was paid across 8 transactions to 1 doctors.
The most common payment nature for RENVELA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($79,829, 50.5% of total).
RENVELA is associated with 1 research study, including "Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease" ($5,498).